News

DINAMIQS opens cGMP manufacturing facility for viral vectors

DINAMIQS, a Siegfried company (SIX: SFZN), today inaugurated its state-of-the-art cGMP manufacturing facility for viral vectors — the first of its kind in Switzerland. The new facility enables end-to-end manufacturing of viral vector gene therapies, from molecule design to aseptic drug product filling. As part of this facility, new lab...

read more

KUORI participates in Fashion for Good initiative

„If adidas, Target & Zalando can rethink plastics, what’s stopping the rest?” 👟✨ We are proud to see leading players taking real action against the massive environmental impacts of footwear production. Their commitment to testing and validating bio-based alternatives shows that disruptive innovation requires courage and collaboration. 💡 It’s inspiring to be...

read more

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSure

CINCINNATI, September 22, 2025 — Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and commercialization of innovative solutions for men’s health and oncology, today announced that its wholly owned subsidiary, Proteomedix AG (“Proteomedix”) has  signed a licensing agreement, with Immunovia...

read more

Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research

BOSTON, Massachusetts and ZUERICH, Switzerland – September 22, 2025 (GLOBE NEWSWIRE) – Biognosys, a pioneer in next-generation proteomics services and software, today announced the expansion of its contract research organization (CRO) services to include quantitative biocrates metabolomics and lipidomics. These services will be offered both in Europe as well as...

read more